Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2003
11/06/2003WO2003091447A2 D1-1 nucleic acids, polypeptides and related methods
11/06/2003WO2003091443A1 Synthetic transfer complex and method for transferring nucleic acids
11/06/2003WO2003091442A1 Improved chimeric glycoproteins and pseudotyped lentiviral vectors
11/06/2003WO2003091439A1 Reporter-selectable hepatitis c virus replicon
11/06/2003WO2003091438A1 Genetic vaccine against rna-viral infections
11/06/2003WO2003091437A1 Chimeric camp factors for vaccination against streptococcus infection
11/06/2003WO2003091436A1 Novel 35 kd protein
11/06/2003WO2003091435A1 Novel proteins and dnas encoding the same
11/06/2003WO2003091434A1 Novel protein and dna thereof
11/06/2003WO2003091429A1 Antimicrobial polypeptide and utizliation thereof
11/06/2003WO2003091428A1 Novel proteins and dnas encoding the same
11/06/2003WO2003091427A1 Kidney disease-associated genes expressed in proximal tubule
11/06/2003WO2003091418A2 Novel essential fungal polynucleotides, polypeptides, and methods of use
11/06/2003WO2003091415A2 Fluorobodies and chromobodies: binding ligands with intrinsic fluorescence and color
11/06/2003WO2003091414A2 Adipocyte complement related protein zacrp8
11/06/2003WO2003091413A2 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same
11/06/2003WO2003091412A2 Generation of plants with improved pathogen resistance
11/06/2003WO2003091411A2 Semisynthetic protein-based site-directed probes for identification and inhibition of active sites, and methods therefor
11/06/2003WO2003091409A2 Identification of compounds which stimulate bone formation using a cell-based screening assay targeting bmp signaling
11/06/2003WO2003091403A2 Genetic and epigenetic manipulation of abc transporters and ecto-phosphatases
11/06/2003WO2003091401A2 Multi plasmid system for the production of influenza virus
11/06/2003WO2003091400A2 Contraceptive targets
11/06/2003WO2003091399A2 Production and use of salt tolerant and culture density tolerant organisms
11/06/2003WO2003091393A2 Nucleic “acid molecules encoding human proteins, and uses thereof”
11/06/2003WO2003091390A2 Regulation of gene expression by neuromodulators and discovery of a novel ngf-induced protein termed pincher
11/06/2003WO2003091388A2 Polymorphic olfactory receptor genes and arrays, kits and methods utilizing them
11/06/2003WO2003091386A2 A new family of picornaviruses
11/06/2003WO2003091385A2 Assay methods relating to the action of geminin in the licensing of dna replication complexes in transformed cells
11/06/2003WO2003091384A2 A role for survivin in apoptosis of myeloid cells
11/06/2003WO2003091383A2 Epha2 antigen t epitopes
11/06/2003WO2003091381A2 Height-related gene
11/06/2003WO2003091284A1 Anticoagulants
11/06/2003WO2003091283A1 Gelatin derivatives and high-molecular micelles comprising the same
11/06/2003WO2003091282A1 Histamine receptor h3 ordinary activity mutant and utilization thereof
11/06/2003WO2003091281A1 Pain receptor gene and protein
11/06/2003WO2003091280A1 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell or hematopoietic progenitor cell, and dna coding for the same
11/06/2003WO2003091279A2 COMBINATION VACCINES INCLUDING IMMUNOGENIC GapC AND CAMP FACTOR POLYPEPTIDES
11/06/2003WO2003091278A1 Gamma-secretase inhibitors
11/06/2003WO2003091277A2 Haplotypes of the cetp gene
11/06/2003WO2003091275A2 Compositions containing anti-hiv peptides and methods of use
11/06/2003WO2003091274A2 Use of alpha-s2 casein precursor-derived peptided
11/06/2003WO2003091271A1 Alternatively spliced nucleic acid molecules
11/06/2003WO2003091269A1 A gene abnormally expressed in autoimmune diseases and malignancies
11/06/2003WO2003091266A2 Protein stabilisation using chaperone proteins
11/06/2003WO2003090788A1 DECOY FOR TREATING AND/OR PREVENTING Th2 CYTOKINE-ASSOCIATED ALLERGIC DISEASE, GATA3 MUTANT PROTEIN AND MEDICINAL COMPOSITIONS CONTAINING THE SAME
11/06/2003WO2003090774A1 Mannose binding lectin and uses thereof
11/06/2003WO2003090719A1 Histidine copolymer and methods for using same
11/06/2003WO2003090687A2 Using heat shock proteins to increase immune response
11/06/2003WO2003090667A2 Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the hpv-16 virus
11/06/2003WO2003090666A2 Glucocorticoid receptor protein crystals
11/06/2003WO2003090664A2 Mutated hpv-16 e7 polypeptide, pharmaceutical composition comprising it and its preparation process
11/06/2003WO2003090514A2 Adipocyte complement related protein zacrp14
11/06/2003WO2003080112A3 Imidazoquinolineamines as adjuvants in hiv dna vaccination
11/06/2003WO2003062269A3 Corticotropin releasing factor receptor 2 agonists
11/06/2003WO2003060099A3 Methods and apparatus for spinning spider silk protein
11/06/2003WO2003059945A3 Soluble recombinant protein production
11/06/2003WO2003055983A3 Targeted retrograde gene delivery to motor neurons
11/06/2003WO2003054009A3 Apoptotically active peptides
11/06/2003WO2003046570A3 Glycoprotein and apolipoprotein biopolymer markers predictive of alzheimers disease
11/06/2003WO2003038112A3 A composition and method to alter lean body mass and bone properties in a subject
11/06/2003WO2003038036A3 Rescue of gonadotropin releasing hormone receptor mutants
11/06/2003WO2003033011A3 Repetitive motifs from salivary proline rich proteins, mucin and collagen
11/06/2003WO2003031939A3 Protein modification and maintenance molecules
11/06/2003WO2003027321A3 Methods for diagnosis and treatment of diseases associated with altered expression of neurogranin
11/06/2003WO2003027263A3 Proteins associated with cell growth, differentiation, and death
11/06/2003WO2003027242A3 Fas ligand
11/06/2003WO2003025167A3 Cultured stromal cells and uses thereof
11/06/2003WO2003025147A3 Novel polynucleotides and proteins encoded thereby
11/06/2003WO2003015714A3 Compositions and therapeutic methods for viral infection
11/06/2003WO2003012106A3 Regulating nucleic acid for expressing a polynucleotide of interest specifically in the endothelium of a plant seed and uses thereof
11/06/2003WO2003012069A3 Compositions and methods for generating chimeric heteromultimers
11/06/2003WO2003009804A3 Conformationally constrained parathyroid hormone (pth) analogs
11/06/2003WO2003006674A3 CRYSTALS AND STRUCTURES OF ArnB AMINOTRANSFERASES
11/06/2003WO2003006617A3 Crystals and structures of perosamine synthase homologs
11/06/2003WO2003006506A3 Protease inhibitor conjugates and antibodies useful in immunoassay
11/06/2003WO2003006496A3 Protein variants of neocarzinostatine and its homologues and their use
11/06/2003WO2003005880A3 Replikin peptides and uses thereof
11/06/2003WO2003003906A3 Diagnostic and screening methods for bladder cancer
11/06/2003WO2003002611A3 Fusion proteins, method for the production and use thereof
11/06/2003WO2003002604A3 G protein coupled receptors and dna sequences thereof
11/06/2003WO2003002061A3 Compositions and methods for treating atherosclerosis
11/06/2003WO2002102318A3 Eglin c based drugs for treatment of disease
11/06/2003WO2002098916A3 Transcriptional regulator of genes involved in the control of cell growth or cell proliferation. use of said regulator as a therapeutic or diagnostic agent
11/06/2003WO2002096939A3 Adenovirus protein ix, its domains involved in capsid assembly, transcriptional activity and nuclear reorganization
11/06/2003WO2002095008A3 Methods of modulating surfactant phospholipid production
11/06/2003WO2002094313A3 Vaccine composition
11/06/2003WO2002085934A3 Antibacterial peptides, compositions containing same and uses thereof
11/06/2003WO2002083903A3 West nile virus epitopes and uses thereof
11/06/2003WO2002083711A3 Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies
11/06/2003WO2002081641A3 Gene scc-112 and diagnostic and therapeutic uses thereof
11/06/2003WO2002079401A3 Novel rgs9 protein binding interactions and methods of use thereof
11/06/2003WO2002079386A3 Isolated human ras-like proteins, nucleic and acid molecules encoding these human ras-like proteins, and uses thereof
11/06/2003WO2002079242A3 Adp-ribosylating bacterial toxins
11/06/2003WO2002077200A3 Efficient methods for isolating functional g-protein coupled receptors and identifying active effectors and efficient methods to isolate proteins involved in olfaction and efficient methods to isolate and identifying active effectors
11/06/2003WO2002076482B1 USE OF IKK-β INHIBITORS AND METHOD FOR DISCOVERY OF SAID INHIBITORS
11/06/2003WO2002075317A3 Screening for drugs against disorders associated with schizophrenia
11/06/2003WO2002074804A3 Use of binding domains of presenilins and transmembrane proteins for drug screening
11/06/2003WO2002072631A3 Mhc molecule constructs and their usesfor diagnosis and therapy
11/06/2003WO2002072600A3 Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections
11/06/2003WO2002070667A3 High level insect expression of rage proteins
1 ... 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 ... 2916